Latest Conference Articles

The treatment of pediatric glaucoma can be successful if caught early, and sometimes that can mean a surgical procedure on the day of the first visit to a specialist.

Only one in 10,000 children will be diagnosed with pediatric glaucoma. If the condition is caught soon enough, surgical options can help treat the condition and give the patients a regular quality of life for their future.

More like a whispering assistant on their shoulder than a new set of eyes, a device by OrCam seems capable of providing the blind a great deal of assistance.

In a retrospective comparison of post-implantation cases of residual refractive astigmatism, researches found AcrySof's intraocular lenses less likely to misalign.

The mortality rate of AMD patients who received a bevacizumab injection 3 or 6 months after stroke was, in the study’s words, “worrying” compared to the rate of those who did not.

Presented at the American Academy of Ophthalmology 2016 Annual Meeting (AAO 2016), one study looked at how vitamin D is involved in the world of uveitis.

With Congenital Zika Syndrome affecting not only the brain, but also the ears and eyes of patients it is important to have properly trained specialists in these fields and others to give them the treatment they need.

There is a well known connection between the Zika virus and neurological issues. Continued research of the virus has also shown a connection to vision impairment and other problems as well.

The Defense and Veterans Eye Injury and Vision Registry monitors damage to the eyes of military members, in hopes of synchronizing care across departments and informing eye protection policy in the armed forces.

Presented this week in Chicago at the American Academy of Ophthalmology 2016 Meeting, a novel new mobile application called Uvemaster may make it easier for clinicians to specifically diagnose uveitis.

Explaining diabetic macular edema to patients can be a challenge in itself. Going further to explain the injection process can take even more care for eye care professionals.

The treatment of diabetic retinopathy, particularly diabetic macular edema has come a long way over the past decade, especially since the approval of aflibrecept to treat these patients.

Researchers from the University of Pittsburgh compared the AmpliVue device to existing detection methods for ocular herpes simplex virus, affirming its accuracy and efficiency.

Speaking at the American Academy of Ophthalmology 2016 Meeting in Chicago, K. V. Chalam, MD, expressed the advantage of using non-invasive OCT angiography (OCT-A) as opposed to the older fluorescein angiography as essentially a difference between imaging in three dimensions or two.

Italian researchers found that supplementing ranibizumab treatment with the daily administration of an NSAID solution improved AMD symptoms better than ranibizumab alone, and believe over time greater statistical significance will emerge.

Difluprednate, a steroid stronger than prednisolone, was recently tested for treatment of macular edema and vitritis in cases of posterior/intermediate uveitis, and its impact was noticeable.

Does adherence to the Mediterranean diet reduce the risk of age-related macular degeneration? Portuguese researchers attempted to determine the AMD-preventative nature of the popular regional diet, which is commonly associated with fish, fruit, grains, and the occasional splash of wine.

Sleep quality and subsequent mood have long, and logically, been correlated. Now, researchers from Japan sought to see how a third consideration, ocular function, fits into that equation.

Simple at-home vision tests can red flag early signs of wet age-related macular degeneration (AMD). But which one is the best?

Although differences between treatment groups in best-corrected visual acuity were not statistically significant, combination treatment reduced central macular thickness and macular volume statistically significantly more than bevacizumab alone.

While estrogen therapy may not be the best option for all women in menopause, there is an effort underway to help educate patients and providers alike as to how best to approach this topic to provide the best results possible.

There are several products on the market designed to help patients manage the symptoms associated with menopause. New research was recently presented on one option which does not include progesterone and what that means for care.

At The North American Menopause Society 27th Annual Meeting (NAMS) in Orlando, Florida, Janet Carpenter, PhD, RN, Indiana University discussed her latest research in nonhomonal alternatives for women experiencing hot flashes including a clinical hypnosis protocol.

At The North American Menopause Society 27th Annual meeting (NAMS), Holly Thomas, MD, MS, University of Pittsburgh, discussed her program of research mainly focuses on how sex changes for women as they move through midlife and into older age.

At The North American Menopause Society 27th Annual Meeting (NAMS), Rebecca Thurston, PhD, University of Pittsburgh, discussed her research on the relationship between sleep and cardiovascular disease in menopause patients.

As Peter Schnatz, DO, Reading Health System, completes his term as President of NAMS, he reflected on the initial goals he'd had before assuming his position. His primary initiative was to bring the best care they could to menopausal women. Schnatz said they'd been working really hard on reopening the conversation of the use and utilization of hormonal therapy.

Peter Schnatz, DO, Reading Health System, current President of The North American Menopause Society (NAMS), spoke about his presidential address, which discussed breast arterial calcification (BAC) and the association with risk factors and atheroscleratic cardiovascular disease.

There is limited data in this population, but some research says that women shouldn't be starting the therapy after the age of 60. However, hormone therapies offer bone protection, which opens the door discussion on usage.

Hadine, Joffe, MD, MSc, explained at The North American Menopause Society 27th Annual Meeting (NAMS), that their research validates there's a biological basis for these symptoms and that these are the brains' responses to hormone changes and the symptom manifestations of those hormone changes.

At The North American Menopause Society 27th Annual Meeting (NAMS), Hadine Joffe, MD, MSc, Brigham and Women's Hospital explained that she always has her patients use sleep hygiene, and that there are some really key strategies that has no side effects.